Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants

Pediatric Nephrology

Volumn 24, Issue 3, 2009, Pages 497-505

  Turcu, Rodica ^a,b   Patterson, Maria Jevitz ^a,c,d   Omar, Said ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University and Sparrow Health System   (United States)

^c NONE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Amphotericin B; ELBW infants; Extremely premature infants; Fungal infection; High sodium intake; Nephrotoxicity

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CREATININE; FLUCONAZOLE;

ARTICLE; BIRTH WEIGHT; CANDIDA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; GESTATIONAL AGE; HIGH SODIUM INTAKE; HUMAN; HYPONATREMIA; INFANT; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ONSET AGE; PREMATURITY; PRIORITY JOURNAL; SYSTEMIC MYCOSIS; TREATMENT DURATION; URINE VOLUME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY; MALE; POTASSIUM, DIETARY; RETROSPECTIVE STUDIES; SODIUM, DIETARY;

EID: 59849122833     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-1050-4     Document Type: Article

References (34)

1. Richardson DK, Gray JE, Gortmaker SL, Goldmann DA, Pursley DM, McCormick MC (1998) Declining severity adjusted mortality: Evidence of improving neonatal intensive care. Pediatrics 102:893-899
2. Noyola DE, Fernandez M, Moylett EH, Baker CJ (2001) Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 32:1018-1023
3. Fernandez M, Moylett EH, Noyola DE, Baker CJ (2000) Candidal meningitis in neonates: A 10-year review. Clin Infect Dis 31:458-463
4. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK (2002) Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291
5. Kaufman D (2004) Fungal infections in very low birth weight infant. Curr Opin Infect Dis 17:253-259
6. Karlowicz MG, Hashimoto LN, Kelly RE, Buescher ES (2000) Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 106:E63
7. Saxen H, Virtanen M, Carlson P, Hoppu K, Pohjavuori M, Vaara M, Vuopio-Varkila J, Peltola H (1995) Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J 14:776-781
8. Faix RG (1992) Invasive neonatal candidiasis: Comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 11:88-93
9. Baley JE, Kliegman RM, Fanaroff AA (1984) Disseminated fungal infections in very low-birth-weight infants: Clinical manifestations and epidemiology. Pediatrics 73:144-152
10. Friedman S, Richardson SE, Jacobs SE, O'Brien K (2000) Systemic Candida infection in extremely low birth weight infants: Short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 19:499-504
11. Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Schmidt AB, Sanza LT, Shutt KA, Fridkin SK (2005) Determining risk factors for candidemia among newborn infants from population-based surveillance. Pediatr Infect Dis J 24:601-604
12. Rowen JL, Tate JM (1998) Management of neonatal candidiasis. Neonatal Candidiasis Study Group. Pediatr Infect Dis J 17:1007-1011
13. Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL (1990) Pharmacokinetics, outcome of treatment, and toxic effects of Amphotericin B and 5-fluorocytosine in neonates. J Pediatr 116:791-797
14. Fanos V, Cataldi L (2000) Amphotericin B-induced nephrotoxicity: A review. J Chemother 12:463-470
15. Stein RS, Alexander JA (1989) Sodium protects against nephrotoxicity in patients receiving Amphotericin B. Am J Med Sci 298:299-304
16. Heideman H (1988) Prevention of Amphotericin B nephrotoxicity: The effect of salt loading and flucytocine. Mycoses 31[Suppl 2]:39-44
17. Ohnishi A, Ohnishi T, Stevenhead W, Robinson RD, Glick A, O'Day DM, Sabra R, Jackson EK, Branch RA (1989) Sodium status influences chronic Amphotericin B nephrotoxicity in rats. Antimicrob Agents Chemother 33:1222-1227
18. Gerkens JF, Branch RA (1980) The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity. J Pharmacol Exp Ther 214:306-311
19. Gardner ML, Godley PJ, Wasan SM (1990) Sodium loading treatment for Amphotericin B-induced nephrotoxicity. DICP Ann Pharmacother 24:940-946
20. Sabra R, Branch RA (1991) Mechanisms of Amphotericin B-induced decrease in glomerular filtration rate in rats. Antimicrob Agents Chemother 35:2509-2514
21. Llanos A, Cieza J, Bernado J, Echevarria J, Biaqqioni I, Sabra R, Branch RA (1991) Effect of salt supplementation on Amphotericin B nephrotoxicity. Kidney Int 40:302-308
22. Anderson CM (1995) Sodium chloride treatment of Amphotericin B nephrotoxicity: Standard of care? West J Med 162:313-317
23. Bernardo JF, Murakami S, Branch RA, Sabra R (1995) Potassium depletion potentiates Amphotericin B-induced toxicity to renal tubules. Nephron 70:235-241
24. Mayer J, Doubek M, Doubek J, Horky D, Scheer P, Stepanek M (2002) Reduced nephrotoxicity of conventional Amphotericin B therapy after minimal nephroprotective measures: Animal experiments and clinical study. J Infect Dis 186:379-388
25. Holler B, Omar SA, Maged DF, Patterson JM (2004) Effects of fluid and electrolyte management on Amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics 113:e608-e616
26. Al Arishi HA, Frayha HH, Kalloghlian A, Alaiyan SA (1998) Liposomal Amphotericin B in neonates with invasive candidiasis. Am J Perinatol 15:643-648
27. Weitkamp JH, Poets CF, Sievers R, Musswessel E, Groneck P, Thomas P, Bartmann P (1998) Candida infection in very low birth weight infants: outcome and nephrotoxicity of treatment with liposomal Amphotericin B (AmBisome). Infection 26:11-15
28. Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ (1999) Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J 18:702-708
29. Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, De Lucia A (1998) Liposomal Amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J 17:146-148
30. Adler-Shohet F, Waskin H, Lieberman JM (2001) Amphotericin B lipid complex for neonatal invasive candidiasis. Arch Dis Child Fetal Neonatal Ed 84:F131-F133
31. Friedlich PS, Steinberg I, Fujitani A, deLemos RA (1997) Renal tolerance with the use of Intralipid-Amphotericin B in low birth weight neonates. Am J Perinatol 14:377-383
32. Miano-Mason TM (1997) Mechanisms and management of Amphotericin B-induced nephrotoxicity. Cancer Pract 5:176-181
33. Butler KM, Rench MA, Baker CJ (1990) Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 9:51-56
34. Thompson JR, Simonsen R, Spindler MA, Southern PM, Cronin RE (1990) Protective effect of KCl loading in gentamicin nephrotoxicity. Am J Kidney Dis 15:583-591